Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced it that it will report its fourth quarter and year-end 2019 financial results on Friday, March 13, 2020.
SEATTLE and VANCOUVER, British Columbia, March 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it that it will report its fourth quarter and year-end 2019 financial results on Friday, March 13, 2020. Company management will host a conference call and live webcast at 8:30 am Eastern Time to report financial results and provide an update on the cytisinicline clinical development program.
To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 6628874. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days.
Achieve Contact
Jason Wong
jwong@bplifescience.com
(415) 375-3340 ext. 4
View original content to download multimedia:http://www.prnewswire.com/news-releases/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2019-financial-results-and-host-conference-call-and-webcast-on-march-13-2020-301014964.html
SOURCE Achieve Life Sciences, Inc.
Company Codes: NASDAQ-SMALL:ACHV
